The Annual ADOPT Summit is a global meeting which covers the full scope of adoptive immunotherapies including CARs, TCRs, NK cells, TILS, γδ T cells, and dendritic cells alongside other emerging cell therapies.
This Summit provides a unique platform for experts to challenge their thinking and explore new and exciting areas of development outside of their specific cell therapy siloes.
Through the collective understanding of industry wide challenges, we will explore various perspectives and approaches being utilised to overcome translational, clinical, scalable manufacturing & bioprocessing challenges.
Scientific and business leaders will gather to futureproof their strategies from preclinical process development through to commercialisation. Learn to demonstrate improved efficacy in solid tumours to make the most of this big opportunity.
Join this unrivalled community of experts as we bring together all the high potential cell immunotherapy areas. Share critical lessons and cross-fertilise ideas as they reveal their strategies, methods and timelines to develop current and future generations of adoptive cell therapies that significantly improve patient outcomes.
“It’s rare to attend a conference and find every talk of interest. They assembled experts and front line companies to create an engaging, informative
conference with just the right amount of networking opportunities.” – EMD Serono